Carl E. Wagner

796 total citations
35 papers, 493 citations indexed

About

Carl E. Wagner is a scholar working on Molecular Biology, Genetics and Biochemistry. According to data from OpenAlex, Carl E. Wagner has authored 35 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 9 papers in Genetics and 7 papers in Biochemistry. Recurrent topics in Carl E. Wagner's work include Retinoids in leukemia and cellular processes (18 papers), Estrogen and related hormone effects (9 papers) and Antioxidant Activity and Oxidative Stress (7 papers). Carl E. Wagner is often cited by papers focused on Retinoids in leukemia and cellular processes (18 papers), Estrogen and related hormone effects (9 papers) and Antioxidant Activity and Oxidative Stress (7 papers). Carl E. Wagner collaborates with scholars based in United States, Japan and South Korea. Carl E. Wagner's co-authors include Kenneth J. Shea, Pamela A. Marshall, Thomas M. Cahill, Peter W. Jurutka, Bertram L. Jacobs, Guillermo Ruíz-Carrascoso, Jeffrey Langland, Michael Heck, Arjan van der Vaart and Ning Ma and has published in prestigious journals such as Journal of the American Chemical Society, Hepatology and Cancer Research.

In The Last Decade

Carl E. Wagner

34 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carl E. Wagner United States 14 199 128 48 41 40 35 493
Н. Л. Шимановский Russia 9 99 0.5× 51 0.4× 53 1.1× 32 0.8× 12 0.3× 93 324
Chunmei He China 16 392 2.0× 44 0.3× 29 0.6× 39 1.0× 50 1.3× 34 730
Qin Tang China 12 200 1.0× 63 0.5× 59 1.2× 21 0.5× 19 0.5× 20 387
Katarzyna Wiktorska Poland 16 393 2.0× 202 1.6× 20 0.4× 29 0.7× 13 0.3× 43 702
Diana Gesto Portugal 8 318 1.6× 47 0.4× 21 0.4× 45 1.1× 21 0.5× 9 647
Mingjuan Ji China 14 227 1.1× 152 1.2× 14 0.3× 30 0.7× 76 1.9× 31 547
Eli Harlev Israel 11 377 1.9× 67 0.5× 163 3.4× 53 1.3× 38 0.9× 17 707
I N Todor Ukraine 10 254 1.3× 79 0.6× 17 0.4× 21 0.5× 18 0.5× 38 563
Huaqian Wang China 15 220 1.1× 45 0.4× 15 0.3× 77 1.9× 100 2.5× 41 529
Maryam Karimi Iran 10 205 1.0× 38 0.3× 18 0.4× 69 1.7× 16 0.4× 24 520

Countries citing papers authored by Carl E. Wagner

Since Specialization
Citations

This map shows the geographic impact of Carl E. Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl E. Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl E. Wagner more than expected).

Fields of papers citing papers by Carl E. Wagner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl E. Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl E. Wagner. The network helps show where Carl E. Wagner may publish in the future.

Co-authorship network of co-authors of Carl E. Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of Carl E. Wagner. A scholar is included among the top collaborators of Carl E. Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl E. Wagner. Carl E. Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wagner, Carl E., et al.. (2024). Rexinoids Induce Differential Gene Expression in Human Glioblastoma Cells and Protein–Protein Interactions in a Yeast Two-Hybrid System. ACS Chemical Neuroscience. 15(15). 2897–2915. 3 indexed citations
2.
Leal, Ana S., Di Zhang, Peter W. Jurutka, et al.. (2022). The rexinoid V-125 reduces tumor growth in preclinical models of breast and lung cancer. Scientific Reports. 12(1). 293–293. 13 indexed citations
3.
Marshall, Pamela A., et al.. (2022). Rexinoids Modulate Effector T Cell Expression of Mucosal Homing Markers CCR9 and α4β7 Integrin and Direct Their Migration In Vitro. Frontiers in Immunology. 13. 746484–746484. 4 indexed citations
4.
Niu, Haixia, Gayla Hadwiger, Heikki Kuusanmäki, et al.. (2020). Endogenous and combination retinoids are active in myelomonocytic leukemias. Haematologica. 106(4). 1008–1021. 7 indexed citations
5.
Zhang, Di, Ana S. Leal, Peter W. Jurutka, et al.. (2019). Testing Novel Pyrimidinyl Rexinoids: A New Paradigm for Evaluating Rexinoids for Cancer Prevention. Cancer Prevention Research. 12(4). 211–224. 13 indexed citations
6.
Wagner, Carl E. & Peter W. Jurutka. (2019). Methods to Generate an Array of Novel Rexinoids by SAR on a Potent Retinoid X Receptor Agonist: A Case Study with NEt-TMN. Methods in molecular biology. 2019. 109–121. 1 indexed citations
7.
Jurutka, Peter W. & Carl E. Wagner. (2019). Methods to Assess Activity and Potency of Rexinoids Using Rapid Luciferase-Based Assays: A Case Study with NEt-TMN. Methods in molecular biology. 2019. 95–108. 1 indexed citations
8.
Wagner, Carl E., et al.. (2018). Dataset on the response of Hut78 cells to novel rexinoids. Data in Brief. 20. 1797–1803. 1 indexed citations
9.
Langland, Jeffrey, Bertram L. Jacobs, Carl E. Wagner, Guillermo Ruíz-Carrascoso, & Thomas M. Cahill. (2018). Antiviral activity of metal chelates of caffeic acid and similar compounds towards herpes simplex, VSV-Ebola pseudotyped and vaccinia viruses. Antiviral Research. 160. 143–150. 74 indexed citations
10.
Heck, Michael, et al.. (2018). Assessment of Novel Vitamin D Receptor Antagonists that Mediate Suppression of Vitamin D Signaling. The FASEB Journal. 32(S1). 1 indexed citations
11.
Kaneko, Ichiro, Ning Ma, Arjan van der Vaart, et al.. (2018). A novel gene expression analytics-based approach to structure aided design of rexinoids for development as next-generation cancer therapeutics. Steroids. 135. 36–49. 10 indexed citations
12.
Gray, Geoffrey, Ning Ma, Carl E. Wagner, & Arjan van der Vaart. (2017). Molecular dynamics simulations and molecular flooding studies of the retinoid X-receptor ligand binding domain. Journal of Molecular Modeling. 23(3). 98–98. 6 indexed citations
13.
Wagner, Carl E., Peter W. Jurutka, Pamela A. Marshall, & Michael Heck. (2016). Retinoid X Receptor Selective Agonists and their Synthetic Methods. Current Topics in Medicinal Chemistry. 17(6). 742–767. 21 indexed citations
14.
Wagner, Carl E., et al.. (2015). Distinct functional modes of SUMOylation for retinoid X receptor alpha. Biochemical and Biophysical Research Communications. 464(1). 195–200. 1 indexed citations
15.
Marshall, Pamela A., Peter W. Jurutka, Carl E. Wagner, et al.. (2015). Analysis of differential secondary effects of novel rexinoids: select rexinoid X receptor ligands demonstrate differentiated side effect profiles. Pharmacology Research & Perspectives. 3(2). e00122–e00122. 18 indexed citations
16.
Marshall, Pamela A., et al.. (2012). Synthesis and biological evaluation of halogenated curcumin analogs as potential nuclear receptor selective agonists. Bioorganic & Medicinal Chemistry. 21(3). 693–702. 16 indexed citations
17.
Wagner, Carl E., Qiang Wang, Alexander Melamed, et al.. (2007). Synthesis and biological evaluation of analogs of altohyrtin C (spongistatin 2). Tetrahedron. 64(1). 124–136. 8 indexed citations
18.
Wagner, Carl E. & Kenneth J. Shea. (2004). Synthesis and First Molecular Structure of a Bis-2-spiro-1-boraadamantane Derivative. Organic Letters. 6(3). 313–316. 8 indexed citations
19.
Wagner, Carl E., Michael L. Mohler, Duane D. Miller, et al.. (2003). Synthesis of 1-Boraadamantaneamine Derivatives with Selective Astrocyte vs C6 Glioma Antiproliferative Activity. A Novel Class of Anti-Hepatitis C Agents with Potential to Bind CD81. Journal of Medicinal Chemistry. 46(14). 2823–2833. 20 indexed citations
20.
Ryswyk, Hal Van, et al.. (1996). Reactivity of Ester Linkages and Pentaammineruthenium(III) at the Monolayer Assembly/Solution Interface. Langmuir. 12(25). 6143–6150. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Н. Л. Шимановский Breakdown of academic impact, for papers by Chunmei He Breakdown of academic impact, for papers by Qin Tang Breakdown of academic impact, for papers by Katarzyna Wiktorska Breakdown of academic impact, for papers by Diana Gesto Breakdown of academic impact, for papers by Mingjuan Ji Breakdown of academic impact, for papers by Eli Harlev Breakdown of academic impact, for papers by I N Todor Breakdown of academic impact, for papers by Huaqian Wang Breakdown of academic impact, for papers by Maryam Karimi
Rankless by CCL
2026